Global Spinal and Bulbar Muscular Atrophy Treatment Market Growth (Status and Outlook) 2022-2028
- LP 4822921
- 85 Pages
- February 2022
- Pharmaceuticals
The United States Spinal and Bulbar Muscular Atrophy Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Spinal and Bulbar Muscular Atrophy Treatment market, reaching US$ million by the year 2028. As for the Europe Spinal and Bulbar Muscular Atrophy Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Spinal and Bulbar Muscular Atrophy Treatment players cover AbbVie, Pfizer, GlaxoSmithKline, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Spinal and Bulbar Muscular Atrophy Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
5α-Reductase Inhibitors
Gonadotropin-releasing Hormone Agonists
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AbbVie
Pfizer
GlaxoSmithKline
Johnson & Johnson
Century Pharmaceuticals
Astellas Pharma
Sanofi
Boehringer Ingelheim International
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size 2017-2028
2.1.2 Spinal and Bulbar Muscular Atrophy Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Spinal and Bulbar Muscular Atrophy Treatment Segment by Type
2.2.1 5α-Reductase Inhibitors
2.2.2 Gonadotropin-releasing Hormone Agonists
2.3 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
2.3.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type (2017-2022)
2.4 Spinal and Bulbar Muscular Atrophy Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Orthopedic Clinics
2.4.3 Ambulatory Surgical Centers
2.5 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
2.5.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application (2017-2022)
3 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Player
3.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Players
3.1.1 Global Spinal and Bulbar Muscular Atrophy Treatment Revenue by Players (2020-2022)
3.1.2 Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Spinal and Bulbar Muscular Atrophy Treatment by Regions
4.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (2017-2022)
4.2 Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth (2017-2022)
4.3 APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth (2017-2022)
4.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2017-2022)
5.2 Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022)
5.3 Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2017-2022)
6.2 APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022)
6.3 APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Spinal and Bulbar Muscular Atrophy Treatment by Country (2017-2022)
7.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022)
7.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment by Region (2017-2022)
8.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.1 Global Spinal and Bulbar Muscular Atrophy Treatment Forecast by Regions (2023-2028)
10.1.1 Global Spinal and Bulbar Muscular Atrophy Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Spinal and Bulbar Muscular Atrophy Treatment Forecast
10.1.3 APAC Spinal and Bulbar Muscular Atrophy Treatment Forecast
10.1.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Forecast
10.1.5 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Forecast
10.2 Americas Spinal and Bulbar Muscular Atrophy Treatment Forecast by Country (2023-2028)
10.2.1 United States Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.2.2 Canada Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.2.3 Mexico Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.2.4 Brazil Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.3 APAC Spinal and Bulbar Muscular Atrophy Treatment Forecast by Region (2023-2028)
10.3.1 China Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.3.2 Japan Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.3.3 Korea Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.3.4 Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.3.5 India Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.3.6 Australia Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Forecast by Country (2023-2028)
10.4.1 Germany Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.4.2 France Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.4.3 UK Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.4.4 Italy Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.4.5 Russia Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.5 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.5.2 South Africa Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.5.3 Israel Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.5.4 Turkey Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.5.5 GCC Countries Spinal and Bulbar Muscular Atrophy Treatment Market Forecast
10.6 Global Spinal and Bulbar Muscular Atrophy Treatment Forecast by Type (2023-2028)
10.7 Global Spinal and Bulbar Muscular Atrophy Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Product Offered
11.1.3 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Product Offered
11.2.3 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Product Offered
11.3.3 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Product Offered
11.4.3 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Century Pharmaceuticals
11.5.1 Century Pharmaceuticals Company Information
11.5.2 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Product Offered
11.5.3 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Century Pharmaceuticals Main Business Overview
11.5.5 Century Pharmaceuticals Latest Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Information
11.6.2 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Product Offered
11.6.3 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Astellas Pharma Main Business Overview
11.6.5 Astellas Pharma Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Product Offered
11.7.3 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Boehringer Ingelheim International
11.8.1 Boehringer Ingelheim International Company Information
11.8.2 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Product Offered
11.8.3 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Boehringer Ingelheim International Main Business Overview
11.8.5 Boehringer Ingelheim International Latest Developments
12 Research Findings and Conclusion
Table 1. Spinal and Bulbar Muscular Atrophy Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 5α-Reductase Inhibitors
Table 3. Major Players of Gonadotropin-releasing Hormone Agonists
Table 4. Spinal and Bulbar Muscular Atrophy Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type (2017-2022)
Table 7. Spinal and Bulbar Muscular Atrophy Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application (2017-2022)
Table 10. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Player (2020-2022)
Table 12. Spinal and Bulbar Muscular Atrophy Treatment Key Players Head office and Products Offered
Table 13. Spinal and Bulbar Muscular Atrophy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Regions (2017-2022)
Table 18. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Country (2017-2022)
Table 20. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type (2017-2022)
Table 22. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application (2017-2022)
Table 24. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Region (2017-2022)
Table 26. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type (2017-2022)
Table 28. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application (2017-2022)
Table 30. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Country (2017-2022)
Table 32. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type (2017-2022)
Table 34. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Spinal and Bulbar Muscular Atrophy Treatment
Table 43. Key Market Challenges & Risks of Spinal and Bulbar Muscular Atrophy Treatment
Table 44. Key Industry Trends of Spinal and Bulbar Muscular Atrophy Treatment
Table 45. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 51. AbbVie Details, Company Type, Spinal and Bulbar Muscular Atrophy Treatment Area Served and Its Competitors
Table 52. AbbVie Spinal and Bulbar Muscular Atrophy Treatment Product Offered
Table 53. AbbVie Spinal and Bulbar Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AbbVie Main Business
Table 55. AbbVie Latest Developments
Table 56. Pfizer Details, Company Type, Spinal and Bulbar Muscular Atrophy Treatment Area Served and Its Competitors
Table 57. Pfizer Spinal and Bulbar Muscular Atrophy Treatment Product Offered
Table 58. Pfizer Main Business
Table 59. Pfizer Spinal and Bulbar Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Pfizer Latest Developments
Table 61. GlaxoSmithKline Details, Company Type, Spinal and Bulbar Muscular Atrophy Treatment Area Served and Its Competitors
Table 62. GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Product Offered
Table 63. GlaxoSmithKline Main Business
Table 64. GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. GlaxoSmithKline Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Spinal and Bulbar Muscular Atrophy Treatment Area Served and Its Competitors
Table 67. Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Johnson & Johnson Latest Developments
Table 71. Century Pharmaceuticals Details, Company Type, Spinal and Bulbar Muscular Atrophy Treatment Area Served and Its Competitors
Table 72. Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Product Offered
Table 73. Century Pharmaceuticals Main Business
Table 74. Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Century Pharmaceuticals Latest Developments
Table 76. Astellas Pharma Details, Company Type, Spinal and Bulbar Muscular Atrophy Treatment Area Served and Its Competitors
Table 77. Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Product Offered
Table 78. Astellas Pharma Main Business
Table 79. Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Astellas Pharma Latest Developments
Table 81. Sanofi Details, Company Type, Spinal and Bulbar Muscular Atrophy Treatment Area Served and Its Competitors
Table 82. Sanofi Spinal and Bulbar Muscular Atrophy Treatment Product Offered
Table 83. Sanofi Main Business
Table 84. Sanofi Spinal and Bulbar Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Sanofi Latest Developments
Table 86. Boehringer Ingelheim International Details, Company Type, Spinal and Bulbar Muscular Atrophy Treatment Area Served and Its Competitors
Table 87. Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Product Offered
Table 88. Boehringer Ingelheim International Main Business
Table 89. Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Boehringer Ingelheim International Latest Developments
List of Figures
Figure 1. Spinal and Bulbar Muscular Atrophy Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type in 2021
Figure 7. Spinal and Bulbar Muscular Atrophy Treatment in Hospitals
Figure 8. Global Spinal and Bulbar Muscular Atrophy Treatment Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Spinal and Bulbar Muscular Atrophy Treatment in Orthopedic Clinics
Figure 10. Global Spinal and Bulbar Muscular Atrophy Treatment Market: Orthopedic Clinics (2017-2022) & ($ Millions)
Figure 11. Spinal and Bulbar Muscular Atrophy Treatment in Ambulatory Surgical Centers
Figure 12. Global Spinal and Bulbar Muscular Atrophy Treatment Market: Ambulatory Surgical Centers (2017-2022) & ($ Millions)
Figure 13. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application in 2021
Figure 14. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Player in 2021
Figure 15. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Spinal and Bulbar Muscular Atrophy Treatment Value Market Share by Country in 2021
Figure 21. Americas Spinal and Bulbar Muscular Atrophy Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application in 2021
Figure 23. United States Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application in 2021
Figure 29. China Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Spinal and Bulbar Muscular Atrophy Treatment Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
